Optical characteristics after Descemet membrane endothelial keratoplasty: 1-year results.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 17 04 2020
accepted: 27 09 2020
entrez: 14 10 2020
pubmed: 15 10 2020
medline: 15 12 2020
Statut: epublish

Résumé

To evaluate the corneal characteristics after Descemet membrane endothelial keratoplasty (DMEK) compared with normal corneas. Patients who underwent DMEK at Yokohama Minami Kyosai Hospital were included and prospectively evaluated pre-operatively and at postoperative months 1, 3, 6, and 12, and compared to healthy controls. Corneal characteristics evaluated included corneal curvature (keratometric value [KV]; D), central corneal thickness (CCT), peripheral corneal thickness (PCT), and corneal higher-order aberrations [HOAs] at 6.0 mm diameter, calculated by anterior segment optical coherence tomography and logarithm of the minimal angle of resolution [logMAR]. A total of 30 eyes of 30 patients (6 men, 24 women, mean age 73.4 ± 7.4 years) were included and compared with 31 age-matched healthy control eyes (13 men, 18 women; mean age 73.0 ± 6.7 years). LogMAR after DMEK improved from 0.87 ± 0.07 preoperatively to 0.04 ± 0.07 at 12 months postoperatively (p<0.001). Although anterior KVs of DMEK eyes were similar to those of control eyes, posterior KVs were significantly larger (-6.4 ± 0.3 D vs. -6.3 ± 0.2 D; p = 0.02). Total HOAs after DMEK improved from 1.94 ± 1.05 μm preoperatively to 1.05 ± 0.16 μm at 12 months postoperatively (p<0.001), which was significantly higher than that in control eyes (0.63 ± 0.06) (p<0.001). Despite the similar CCTs in the two groups, the PCT was significantly larger in DMEK eyes (704 ± 41 μm vs 669 ± 38 μm, p = 0.002) at 12 months. Despite achieving good visual function and excellent corneal clarity, eyes that underwent DMEK showed a steeper posterior KV and higher corneal HOAs than normal eyes even at 12 months after surgery.

Identifiants

pubmed: 33052928
doi: 10.1371/journal.pone.0240458
pii: PONE-D-20-11108
pmc: PMC7556451
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0240458

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Graefes Arch Clin Exp Ophthalmol. 2019 Feb;257(2):321-329
pubmed: 30564906
Cornea. 2011 Dec;30(12):1341-5
pubmed: 21955628
Am J Ophthalmol. 2017 Mar;175:148-158
pubmed: 28040524
PLoS One. 2017 Nov 30;12(11):e0188832
pubmed: 29190797
PLoS One. 2016 Aug 18;11(8):e0161075
pubmed: 27536778
Cornea. 2010 Oct;29(10):1086-90
pubmed: 20567202
Cornea. 2006 Sep;25(8):886-9
pubmed: 17102661
Cornea. 2019 May;38(5):535-541
pubmed: 30681522
Cornea. 2015 Nov;34 Suppl 11:S128-35
pubmed: 26448170
Cornea. 2016 Dec;35(12):1562-1568
pubmed: 27362879
Am J Ophthalmol. 2014 Jul;158(1):71-79.e1
pubmed: 24784873
Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2575-84
pubmed: 24008847
J Cataract Refract Surg. 2009 Apr;35(4):688-94
pubmed: 19304090
Cornea. 2006 Sep;25(8):987-90
pubmed: 17102683
Ophthalmology. 2009 Dec;116(12):2361-8
pubmed: 19875170
Ophthalmology. 2017 Apr;124(4):512-518
pubmed: 28094043
Curr Opin Ophthalmol. 2007 Jul;18(4):290-4
pubmed: 17568204
J Refract Surg. 2010 Dec;26(12):972-9
pubmed: 20166622
Cornea. 2019 Aug;38(8):970-975
pubmed: 31135493
Int Ophthalmol Clin. 2000 Winter;40(1):27-43
pubmed: 10713912
Ophthalmology. 2012 Mar;119(3):536-40
pubmed: 22218143
Biomed Res Int. 2017;2017:9720389
pubmed: 28676862
Ophthalmology. 2012 Mar;119(3):528-35
pubmed: 22197439
Cornea. 2016 Jun;35(6):765-71
pubmed: 27032019
Cornea. 2018 Sep;37(9):1185-1188
pubmed: 29634673
Invest Ophthalmol Vis Sci. 2011 Aug 05;52(9):6222-9
pubmed: 21724912
Am J Ophthalmol. 2011 Oct;152(4):537-542.e2
pubmed: 21726845
Ophthalmology. 2019 Jul;126(7):946-957
pubmed: 30776384

Auteurs

Takahiko Hayashi (T)

Department of Ophthalmology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan.
Department of Ophthalmology, University of Cologne, Cologne, Germany.
Department of Ophthalmology, Jichi Medical University, Shimotsuke, Tochigi, Japan.
Department of Ophthalmology, Yokohama City University School of Medicine, Kanagawa, Japan.
Department of Technology and Design Thinking for Medicine (DT2M), Hiroshima University, Higashihiroshima, Japan.

Akira Kobayashi (A)

Department of Ophthalmology, Graduate School of Medical Science, Kanazawa University, Kanazawa, Japan.

Hidenori Takahashi (H)

Department of Ophthalmology, Jichi Medical University, Shimotsuke, Tochigi, Japan.

Itaru Oyakawa (I)

Department of Ophthalmology, Heart Life Hospital, Nakagami-gun, Okinawa, Japan.

Naoko Kato (N)

Department of Ophthalmology, Yokohama Minami Kyosai Hospital, Yokohama, Kanagawa, Japan.
Minamiaoyama Eye Clinic, Minato-ku, Tokyo, Japan.

Takefumi Yamaguchi (T)

Department of Ophthalmology, Tokyo Dental College, Ichikawa General Hospital, Chiba, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH